The Pharmacokinetics and Toxicity of Morning vs. Evening Tobramycin Dosing for Pulmonary Exacerbations of Cystic Fibrosis: A Randomised Comparison

Journal of Cystic Fibrosis - Netherlands
doi 10.1016/j.jcf.2015.07.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy, Tolerance, and Pharmacokinetics of Once Daily Tobramycin for Pseudomonas Exacerbations in Cystic Fibrosis

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1998English

Characterization of Inpatient Cystic Fibrosis Pulmonary Exacerbations

Pediatrics
Child HealthPediatricsPerinatology
2017English

Morning vs Evening Dosing With Doxazosin in Benign Prostatic Hyperplasia: Efficacy and Safety

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
1998English

Inhaled Hypertonic Saline Reduces Pulmonary Exacerbations in Cystic Fibrosis

Thorax
PulmonaryRespiratory Medicine
2006English

Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis

Frontiers in Pharmacology
Pharmacology
2019English

Glucose Tolerance During Pulmonary Exacerbations in Children With Cystic Fibrosis

PLoS ONE
Multidisciplinary
2012English

Treatment of Pulmonary Exacerbations of Cystic Fibrosis Leads to Improved Antioxidant Status

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1999English

Comparison of Morning and Evening/Night Dosing on the Efficacy of Escitalopram in Major Depressive Disorder at Naturalistic Setting

Chronobiology in Medicine
2019English

Blood mRNA Biomarkers for Detection of Treatment Response in Acute Pulmonary Exacerbations of Cystic Fibrosis

Thorax
PulmonaryRespiratory Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy